Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 155030-63-0
2. Emodepside [inn]
3. Bay-44-4400
4. Bay 44-4400
5. Yz647y5gc9
6. Chebi:78739
7. Pf-1022-221
8. (3s,6r,9s,12r,15s,18r,21s,24r)-3,9,15,21-tetraisobutyl-4,6,10,16,18,22-hexamethyl-12,24-bis(4-morpholinobenzyl)-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosan-2,5,8,11,14,17,20,23-octaone
9. Pf 1022-221
10. (3s,6r,9s,12r,15s,18r,21s,24r)-4,6,10,16,18,22-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-12,24-bis[(4-morpholin-4-ylphenyl)methyl]-1,7,13,19-tetraoxa-4,10,16,22-tetrazacyclotetracosane-2,5,8,11,14,17,20,23-octone
11. Cyclo((r)-lactoyl-n-methyl-l-leucyl-(r)-3-(p-morpholinophenyl)lactoyl-n-methyl-l-leucyl-(r)-lactoyl-n-methyl-l-leucyl-(r)-3-(p-morpholinophenyl)lactoyl-n-methyl-l-leucyl)
12. (3~{s},6~{r},9~{s},12~{r},15~{s},18~{r},21~{s},24~{r})-4,6,10,16,18,22-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-12,24-bis[(4-morpholin-4-ylphenyl)methyl]-1,7,13,19-tetraoxa-4,10,16,22-tetrazacyclotetracosane-2,5,8,11,14,17,20,23-octone
13. Emodepsida
14. Emodepsidum
15. Unii-yz647y5gc9
16. Cyclo[(r)-lactoyl-n-methyl-l-leucyl-(r)-3-(p-morpholinophenyl)lactoyl-n-methyl-l-leucyl-(r)-lactoyl-n-methyl-l-leucyl-(r)-3-(p-morpholinophenyl)lactoyl-n-methyl-l-leucyl]
17. Emodepside [mi]
18. Schembl167580
19. Emodepside [green Book]
20. Chembl2104404
21. Dtxsid50165799
22. Procox Component Emodepside
23. Profender Component Emodepside
24. Emodepside Component Of Procox
25. Db11403
26. Emodepside [ema Epar Veterinary]
27. Emodepside Component Of Profender
28. Ncgc00507682-01
29. Ac-31930
30. C18390
31. E74446
32. A929940
33. Q1339032
34. (3s,6r,9s,12r,15s,18r,21s,24r)-3,9,15,21-tetraisobutyl-4,6,10,16,18,22-hexamethyl-12,24-bis[4-(morpholin-4-yl)benzyl]-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclotetracosane-2,5,8,11,14,17,20,23-octone
35. 4,6,10,16,18,22-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-12,24-bis[(4-morpholin-4-ylphenyl)methyl]-1,7,13,19-tetraoxa-4,10,16,22-tetrazacyclotetracosane-2,5,8,11,14,17,20,23-octone
36. 8i2
37. Cyclo [d-2-hydroxypropanoyl-n-methyl-l-leucyl-3-[4-(4-morpholinyl)phenyl]-d-2-hydroxypropanoyl-n-methyl-l-leucyl-d-2-hydroxypropanoyl-n-methyl-l-leucyl-3-[4-(4-morpholinyl)phenyl]-d-2-hydroxypropanoyl-n-methyl-l-leucyl]
38. Cyclo {d-lactoyl-n-methyl-l-leucyl-3-[4-(4-morpholinyl)phenyl]-d-lactoyl-n-methyl-l-leucyl-d-lactoyl-n-methyl-l-leucyl-3-[4-(4-morpholinyl)phenyl]-d-lactoyl-n-methyl-l-leucyl}
39. Cyclo((.alpha.r)-.alpha.-hydroxy-4-(4-morpholinyl)benzenepropanoyl-n-methyl-l-leucyl-(2r)-2-hydroxypropanoyl-n-methyl-l-leucyl-(.alpha.r)-.alpha.-hydroxy-4-(4-morpholinyl)benzenepropanoyl-n-methyl-l-leucyl-(2r)-2-hydroxypropanoyl-n-methyl-l-leucyl)
Molecular Weight | 1119.4 g/mol |
---|---|
Molecular Formula | C60H90N6O14 |
XLogP3 | 9 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 14 |
Exact Mass | 1118.65150157 g/mol |
Monoisotopic Mass | 1118.65150157 g/mol |
Topological Polar Surface Area | 211 Ų |
Heavy Atom Count | 80 |
Formal Charge | 0 |
Complexity | 1900 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antiparasitic Agents
Drugs used to treat or prevent parasitic infections. (See all compounds classified as Antiparasitic Agents.)
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?